Cargando…
Protective immune responses against West Nile virus are primed by distinct complement activation pathways
West Nile virus (WNV) causes a severe infection of the central nervous system in several vertebrate animals including humans. Prior studies have shown that complement plays a critical role in controlling WNV infection in complement (C) 3(−/−) and complement receptor 1/2(−/−) mice. Here, we dissect t...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121216/ https://www.ncbi.nlm.nih.gov/pubmed/16651386 http://dx.doi.org/10.1084/jem.20052388 |
_version_ | 1782141667269148672 |
---|---|
author | Mehlhop, Erin Diamond, Michael S. |
author_facet | Mehlhop, Erin Diamond, Michael S. |
author_sort | Mehlhop, Erin |
collection | PubMed |
description | West Nile virus (WNV) causes a severe infection of the central nervous system in several vertebrate animals including humans. Prior studies have shown that complement plays a critical role in controlling WNV infection in complement (C) 3(−/−) and complement receptor 1/2(−/−) mice. Here, we dissect the contributions of the individual complement activation pathways to the protection from WNV disease. Genetic deficiencies in C1q, C4, factor B, or factor D all resulted in increased mortality in mice, suggesting that all activation pathways function together to limit WNV spread. In the absence of alternative pathway complement activation, WNV disseminated into the central nervous system at earlier times and was associated with reduced CD8(+) T cell responses yet near normal anti-WNV antibody profiles. Animals lacking the classical and lectin pathways had deficits in both B and T cell responses to WNV. Finally, and somewhat surprisingly, C1q was required for productive infection in the spleen but not for development of adaptive immune responses after WNV infection. Our results suggest that individual pathways of complement activation control WNV infection by priming adaptive immune responses through distinct mechanisms. |
format | Text |
id | pubmed-2121216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21212162007-12-13 Protective immune responses against West Nile virus are primed by distinct complement activation pathways Mehlhop, Erin Diamond, Michael S. J Exp Med Articles West Nile virus (WNV) causes a severe infection of the central nervous system in several vertebrate animals including humans. Prior studies have shown that complement plays a critical role in controlling WNV infection in complement (C) 3(−/−) and complement receptor 1/2(−/−) mice. Here, we dissect the contributions of the individual complement activation pathways to the protection from WNV disease. Genetic deficiencies in C1q, C4, factor B, or factor D all resulted in increased mortality in mice, suggesting that all activation pathways function together to limit WNV spread. In the absence of alternative pathway complement activation, WNV disseminated into the central nervous system at earlier times and was associated with reduced CD8(+) T cell responses yet near normal anti-WNV antibody profiles. Animals lacking the classical and lectin pathways had deficits in both B and T cell responses to WNV. Finally, and somewhat surprisingly, C1q was required for productive infection in the spleen but not for development of adaptive immune responses after WNV infection. Our results suggest that individual pathways of complement activation control WNV infection by priming adaptive immune responses through distinct mechanisms. The Rockefeller University Press 2006-05-15 /pmc/articles/PMC2121216/ /pubmed/16651386 http://dx.doi.org/10.1084/jem.20052388 Text en Copyright © 2006, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Mehlhop, Erin Diamond, Michael S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways |
title | Protective immune responses against West Nile virus are primed by distinct complement activation pathways |
title_full | Protective immune responses against West Nile virus are primed by distinct complement activation pathways |
title_fullStr | Protective immune responses against West Nile virus are primed by distinct complement activation pathways |
title_full_unstemmed | Protective immune responses against West Nile virus are primed by distinct complement activation pathways |
title_short | Protective immune responses against West Nile virus are primed by distinct complement activation pathways |
title_sort | protective immune responses against west nile virus are primed by distinct complement activation pathways |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2121216/ https://www.ncbi.nlm.nih.gov/pubmed/16651386 http://dx.doi.org/10.1084/jem.20052388 |
work_keys_str_mv | AT mehlhoperin protectiveimmuneresponsesagainstwestnilevirusareprimedbydistinctcomplementactivationpathways AT diamondmichaels protectiveimmuneresponsesagainstwestnilevirusareprimedbydistinctcomplementactivationpathways |